Divi's Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Divi's Laboratories has a total shareholder equity of ₹137.2B and total debt of ₹50.0M, which brings its debt-to-equity ratio to 0.04%. Its total assets and total liabilities are ₹155.9B and ₹18.7B respectively. Divi's Laboratories's EBIT is ₹21.8B making its interest coverage ratio -7.3. It has cash and short-term investments of ₹36.0B.
Key information
0.04%
Debt to equity ratio
₹50.00m
Debt
| Interest coverage ratio | -7.3x |
| Cash | ₹36.02b |
| Equity | ₹137.17b |
| Total liabilities | ₹18.69b |
| Total assets | ₹155.86b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 532488's short term assets (₹93.4B) exceed its short term liabilities (₹12.9B).
Long Term Liabilities: 532488's short term assets (₹93.4B) exceed its long term liabilities (₹5.8B).
Debt to Equity History and Analysis
Debt Level: 532488 has more cash than its total debt.
Reducing Debt: 532488's debt to equity ratio has reduced from 0.2% to 0.04% over the past 5 years.
Debt Coverage: 532488's debt is well covered by operating cash flow (32960%).
Interest Coverage: 532488 earns more interest than it pays, so coverage of interest payments is not a concern.